California Bancorp BCAL 深 沪
等待开盘 08-22 09:30:00 美东时间
21.31
+0.110
+0.52%
华盛通- 最 高21.505
- 今 开21.42
- 成交量 5.05万股
- 最 低 21.19
- 昨 收 21.20
- 总市值 6.85亿
- 52周最高 22.00
- 市盈率 静 11.07
- 换手率 0.00%
- 52周最低 15.545
- 委 比 -43.86%
- 总股本 3215.05万
- 历史最高 22.00
- 量 比 0.51
- 振 幅 1.49%
- 历史最低 11.57
- 每 手 1
- 风险率 1.46%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Raymond James Initiates Coverage On California BanCorp with Outperform Rating, Announces Price Target of $25
Raymond James analyst David Feaster initiates coverage on California BanCorp (NASDAQ:BCAL) with a Outperform rating and announces Price Target of $25.
08-21 19:43
美股大行评级 | Palantir、Snap、爵士制药获多家大行上调目标价；潜在涨幅176.34%！巴克莱维持Snap(SNAP)"超配"评级，目标价从15美元上调至16美元
今日重点评级关注：巴克莱：维持Snap"超配"评级，目标价从15美元升至16美元；Canaccord Genuity：维持阿梅雷斯克"买入"评级，目标价从59美元升至62美元
08-05 11:45
美股大行评级 | 最高1400美元！花旗、大小摩8家大行上调希捷科技目标价；大行集中调整目标价：康宁、科斯塔、思佳讯遭下调，PayPal、Visa、可口可乐、赛莱默获上调
今日重点评级关注：古根海姆：维持ProMIS Neurosciences"买入"评级，目标价从35美元升至69美元；BTIG：维持Cullinan Therapeutics"买入"评级，目标价从38美元升至39美元
07-30 11:45
美股大行评级 | 潜在涨幅129.15%！HC Wainwright & Co.升Q32 Bio(QTTB)目标价至36美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Q32 Bio"买入"评级，目标价从13美元升至36美元；Chardan Capital：维持ProMIS Neurosciences"买入"评级，目标价从20美元升至33美元
07-29 11:37
DA Davidson Maintains Buy on California BanCorp, Raises Price Target to $25
DA Davidson analyst Gary Tenner maintains California BanCorp (NASDAQ:BCAL) with a Buy and raises the price target from $23.5 to $25.
07-29 03:54
This Regional Bank Just Raised Its Dividend 20%
California BanCorp ($BCAL) has raised its quarterly dividend by 20% as it bolst...
07-27 23:25
California BanCorp raises dividend by 20% to $0.12
California BanCorp (BCAL) declares $0.12/share quarterly dividend, 20% increase from prior dividend of $0.10. Forward yield 2.28% Payable Oct. 15; for shareholders of record Sept. 21; ex-div Sept. 21....
07-27 21:22
Southern Calif Bancorp Q2 EPS $0.44 Beats $0.40 Estimate, Sales $44.905M Miss $45.086M Estimate
Southern Calif Bancorp (NASDAQ:BCAL) reported quarterly earnings of $0.44 per share which beat the analyst consensus estimate of $0.40 by 10 percent. This is a 2.33 percent increase over earnings of $0.43 per share from the same period last year. The company reported quarterly sales of $44.905 milli...
07-27 20:04
美股小盘股成市场关注焦点 兼具成长与估值优势
在大型科技股估值高企、板块轮动加速的背景下，一批兼具强劲增长与合理估值的小盘股公司正成为投资者关注的焦点。分析显示，在医疗保健、银行、金融科技及能源等领域...
06-05 03:39
Small-cap companies with strong growth at modest valuations
Small-cap companies across healthcare, banking, financial technology, and energy are showing some of the strongest growth metrics in the market while still trading at relatively modest valuation level...
06-05 01:58
